
|Articles|February 4, 2022
Daily Medication Pearl: Tavaborole (Kerydin)
Author(s)Saro Arakelians, PharmD
Tavaborole (Kerydin) is indicated for the topical treatment of onychomycosis of the toenails.
Advertisement
Medication Pearl of the Day: Tavaborole (Kerydin)
Indication: Tavaborole (Kerydin) is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes.
Insight:
- Dosing: Apply tavaboroleto affected toenails once daily for 48 weeks.
- Dosage forms:Solution, 5%.
- Adverse events: Common adverse reactions occurring in ≥1% in subjects treated with tavaboroleincluded application site exfoliation, ingrown toenail, application site erythema, and application site dermatitis.
- Mechanism of action: Kerydin is an oxaborole antifungal.
- Manufacturer: Anacor Pharma
Sources:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
FDA Accepts NDA for AD109 for Treatment of Adults With Obstructive Sleep Apnea
3
Up to 5 Cups of Coffee Daily Safe—and Benficial—for Most Adults
4
Could VER-01 Redefine the Role of Cannabis in Chronic Pain Care?
5





































































































